The stock has a 36-month beta value of -1.90. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ALMS is 67.49M, and at present, short sellers hold a 6.87% of that float. On June 03, 2025, the average trading volume of ALMS was 932.55K shares.
ALMS) stock’s latest price update
The stock price of Alumis Inc (NASDAQ: ALMS) has surged by 10.64 when compared to previous closing price of 3.29, but the company has seen a -18.20% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-29 that SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will present at the Jefferies Global Healthcare Conference on June 4, 2025 at 3:10 p.m.
ALMS’s Market Performance
Alumis Inc (ALMS) has experienced a -18.20% fall in stock performance for the past week, with a -20.70% drop in the past month, and a -20.70% drop in the past quarter. The volatility ratio for the week is 5.22%, and the volatility levels for the past 30 days are at 9.25% for ALMS. The simple moving average for the last 20 days is -21.50% for ALMS stock, with a simple moving average of -54.79% for the last 200 days.
Analysts’ Opinion of ALMS
Many brokerage firms have already submitted their reports for ALMS stocks, with Oppenheimer repeating the rating for ALMS by listing it as a “Outperform.” The predicted price for ALMS in the upcoming period, according to Oppenheimer is $32 based on the research report published on January 30, 2025 of the current year 2025.
Robert W. Baird, on the other hand, stated in their research note that they expect to see ALMS reach a price target of $25. The rating they have provided for ALMS stocks is “Outperform” according to the report published on October 31st, 2024.
H.C. Wainwright gave a rating of “Buy” to ALMS, setting the target price at $30 in the report published on October 17th of the previous year.
ALMS Trading at -31.41% from the 50-Day Moving Average
After a stumble in the market that brought ALMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.10% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALMS starting from Tananbaum James B., who purchase 25,000 shares at the price of $4.62 back on May 02 ’25. After this action, Tananbaum James B. now owns 4,227,670 shares of Alumis Inc, valued at $115,500 using the latest closing price.
Tananbaum James B., the Director of Alumis Inc, purchase 20,000 shares at $4.34 during a trade that took place back on May 06 ’25, which means that Tananbaum James B. is holding 4,247,670 shares at $86,800 based on the most recent closing price.
Stock Fundamentals for ALMS
Current profitability levels for the company are sitting at:
- -18.76 for the present operating margin
- 0.04 for the gross margin
The net margin for Alumis Inc stands at -18.16. The total capital return value is set at -1.77. Equity return is now at value -247.05, with -156.54 for asset returns.
Based on Alumis Inc (ALMS), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -9.13.
Currently, EBITDA for the company is -297.6 million with net debt to EBITDA at 0.27. When we switch over and look at the enterprise to sales, we see a ratio of 15.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.73.
Conclusion
To sum up, Alumis Inc (ALMS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
